Biologics Regulatory Affairs Consultant in India
Your Trusted Partner for Biologics Regulatory Affairs Consulting in India. Expert Support for Biologics Registration, Compliance, and Lifecycle Management in India.
Services We Offer
Regulatory Affairs Consulting for Biologics in India
Artixio provides regulatory affairs consulting services for biologics companies looking to operate in the Indian market. We support the registration and lifecycle management of biosimilars, monoclonal antibodies, vaccines, and advanced therapies like cell and gene products.
Our team works closely with clients to prepare regulatory submissions, manage communication with CDSCO, and handle updates across development and post-approval phases. With strong familiarity with India’s biologics guidelines, we help companies stay aligned with local expectations and avoid delays.
Biologics Regulatory Authorities in India:
| Regulatory Body | Role |
|---|---|
| Central Drugs Standard Control Organization (CDSCO) | Main regulatory authority responsible for approval of biologics, including clinical trials, import, manufacture, and marketing. |
| Drug Controller General of India (DCGI) | Head of CDSCO; grants approval for biologics, biosimilars, vaccines, and oversees regulatory decisions. |
| Review Committee on Genetic Manipulation (RCGM) | Reviews preclinical data and grants approval for research involving GMOs and biologics at the research stage. |
CDSCO Regulatory Submission Support For Biologics
Artixio provides regulatory submission and documentation support for biological products in India, helping companies prepare and maintain accurate, complete, and submission-ready regulatory documents. Our support can cover:
Biologics Regulatory Document Submission Support
- Regulatory dossier preparation and review
- Application forms and supporting documents
- Technical and quality documentation
- Regulatory submission planning and coordination
- Responses to regulatory queries and deficiencies
- Document review for regulatory compliance
- Post-submission documentation and updates
- Regulatory authority communication
Biological Products We Support
- Vaccines
- Biosimilars
- Recombinant biological products
- Other applicable biological products
Regulatory Requirements for Biological Products in India
- CDSCO/DCGI and other relevant authorities
- Product-specific requirements
- Manufacturing/import considerations
- Clinical or quality documentation where applicable
Full Regulatory Support for Product Launch and Market Entry in India
Why Artixio for Biologics Regulatory Affairs in India
FAQs
What types of biologics does Artixio support for regulatory approval in India?
We support a wide range of biologics including biosimilars, monoclonal antibodies (mAbs), therapeutic proteins, gene and cell therapies, vaccines, and recombinant products for CDSCO, RCGM, and GEAC submissions.
Do I need approvals from multiple authorities for biologics in India?
Yes. Depending on the product type, you may need approvals from CDSCO (for market authorization), RCGM (for research involving GMOs), and GEAC (for environmental clearance, especially for recombinant biologics).
How long does it take to get a biologic approved in India?
Timelines vary based on product type and data availability. Typically, approval may take 6–12 months for biosimilars with prior global approval. For novel biologics or gene therapies, timelines may be longer due to preclinical and clinical requirements.
Still Have Questions ?
Specialized Regulatory Affairs
Services Across Multiple Industries
Pharmaceuticals
MedTech
Cosmetics
Nutrition
Biologics
Veterinary
Related India Services
Regulatory Affairs Across Multiple Countries
India
Singapore
Mexico
Brazil
Vietnam
Malaysia
Argentina
Colombia
Taiwan
China
European
Thailand
Indonesia
Philippines
USA
Japan
Qatar
South Korea
Insights from Artixio - Tips & Articles
Biologics and Biosimilars Regulation
The Emirates Drug Establishment (EDE) is the single federal authority responsible for Biologics and...
Biologics and Biosimilars Regulation
Biologics and Biosimilars Regulation in Saudi Arabia runs through one authority. That authority is...
Biologics and Biosimilars Regulation
Canada offers a solid market for biologics and biosimilars, but market authorization doesn't come...